163 results
Page 4 of 9
S-8
EX-5.1
e4pyzk2kthuc7wkf
12 Aug 21
Registration of securities for employees
4:50pm
S-8
fgy6cafj3u710hg
12 Aug 21
Registration of securities for employees
4:50pm
S-8
EX-4.8
23dw m4u6ieis
12 Aug 21
Registration of securities for employees
4:50pm
424B5
no808y9ek7
17 Feb 21
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
w6nrc
12 Feb 21
Note Regarding Forward-looking Statements
8:19am
424B5
9sij5kzw16fljb5vi
11 Feb 21
Prospectus supplement for primary offering
5:28pm
8-K
nc81t0rskwpid
20 Oct 20
Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
5:30pm
8-K
EX-10.2
vq9kaqilshdc0
9 Sep 20
Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer
9:30am
8-K
EX-10.1
u66wgj5ksfie h0lu7
9 Sep 20
Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer
9:30am
8-K
hyaua9ll0oo56d3bazws
9 Sep 20
Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer
9:30am
424B3
keo82ze9nb7
8 Jun 20
Prospectus supplement
4:48pm
424B5
mtjq ahlb020
19 May 20
Prospectus supplement for primary offering
5:29pm